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The story continues:  
 the forgotten half of Cochrane’s  
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June 14, 2013 
 
Inaugural Victorian Psycho-oncology Research Conference 
Melbourne, Australia 
“It must be remembered that there is 
nothing more difficult to plan, more 
doubtful of success, nor more dangerous 
to manage than a new system. For the 
initiator has the enmity of all who would 
profit by the preservation of the old 
institution and merely lukewarm 
defenders in those who gain by the new 
ones. ”  
“What I decided I could not 
continue doing was making 
decisions about intervening 
when I had not idea whether I 
was doing more harm than 
good.”          c1972 
“It is surely a great criticism of 
our profession that we have not 
organised a critical summary, by 
specialty or subspecialty, 
adapted periodically, of all 
relevant randomised controlled 
trials”            c1979 
c1971 
Screening mammography: Does it work ? 
• CRUK review (Marmot 
et al Lancet 2012) 
confirmed 20% RRR for 
screening in 50-79yos 
• Affirms likely presence 
of overdiagnosis (see L 
panels) 
• “the Panel estimates 
that for 10,000 UK 
women invited to 
screening from age 50 
for 20 years, about 681 
cancers will be found of 
which  129 will 
represent 
overdiagnosis, and 43 
deaths from breast 
cancer will be 
prevented. In round 
terms, therefore, for 
each breast cancer 
death prevented about 
three overdiagnosed 
cases will be identified 
and treated." 
Routine health checks: Does it work ? 
• NHS Health Check 
programme quickly posted 
an online rebuttal of the 
Cochrane review 
• The Cochrane authors 
sought to post a 
counterpoint defending 
their original SR on the 
same NHS website, but 
was denied 
• Currently the authors are 
attempting to publish the 
scientific and process 
content of the whole saga 
in a general medical 
journal for wider 
dissemination 
MMR and autism: is it real ? 

“…the experimenting society is 
a process utopia…it seeks to 
implement that 
recommendation of Popper’s, ‘a 
social technology is needed 
whose results can be tested by 
piecemeal social engineering.’”            
c1971 
Exploratory meeting 
in 1999 @ 
since 2000 
Going beyond “Does it work?” 
Buying in the bizarre health care bazaar… 
“I believe that cure is rare while the need for care is widespread, and that the 
pursuit of cure at all costs may restrict the supply of care...”  
– Archie Cochrane, 1972 
 

The theory goes… 
Source: Uwe Reinhardt @ NYTimes Economix blog 
Source: www.williamette.edu 
Reality check… 

American 
exceptionalism ? 
Has rationality prevailed with professionals ? 
Source: Isaacs & Fitzgerald BMJ 1999 
Societal values-driven behaviour  
  Egosyntonic resolution 
Psycho-oncology writ large 
• Primarily concerned with the 
psychological, behavioural, 
and ethical aspects of cancer 
• Addresses the 2 major 
psychological dimensions of 
cancer:  
– psychological responses of 
patients to cancer at all stages 
of the disease and that of their 
families and caregivers 
– psychological, behavioural, and 
social factors that may 
influence the disease process  
• That all cancer patients 
throughout the world 
receive optimal 
psychosocial care at all 
stages of disease and 
survivorship 
 
Prof Jon Emery 
Professor of General Practice,  
University of Western Australia. 
Herman Professor of Primary Care Cancer Research, 
University of Melbourne 
Director of PC4 
 

Colorectal cancer risk models 
Breast cancer risk models 
Amir E et al. JNCI J Natl Cancer Inst 2010;jnci.djq088 
© The Author 2010. Published by Oxford University Press. 
Lost in translation 
J Westfall et al JAMA  2007 
How do we get cancer risks models 
used in clinical practice? 
 
Will they alter clinician and patient 
behaviours? 
Developing and 
evaluating complex 
interventions 
Pre-clinical 
Theoretical and 
evidence base 
 
Modelling - phase I 
 
Exploratory trial 
Phase II 
 
Lower Cost 
Higher risk 
Definitive RCT 
Phase III 
 
Higher cost 
Lower risk 
Development of the intervention 
Evaluation of the intervention 
Structural Framework for Development of Complex 
Interventions to Improve Health    (MRC 2000) 
    RAGS studies        
GRAIDS studies  
The RAGs Studies 
 Risk Assessment in GeneticS 
 Computerised pedigree drawing 
and decision support for breast 
and ovarian cancer 
 Theoretical and Phase 1 studies 
 systematic review of primary 
care genetics     Fam Pract 
1999; 16: 426-445  
 qualitative study of RAGs BMJ 
1999; 319: 32-36 
 experimental comparative 
study of RAGs BMJ 2000; 321: 
28-32 
 
 
Genetic 
Skills 
Genetic 
knowledge 
Education & 
training 
GRAIDS 
software via 
NHSnet 
The GRAIDS Trial 
High quality cancer genetic advice 
in primary care 
Generic 
consulting 
skills 
Service model 
innovation 
Lead clinician 
Emery et al Brit J Cancer 2007; 
97:486-493. 
GRAIDS trial design 
 Cluster randomisation 
 Stratified by practice size and distance from genetics 
clinic 
 23 intervention practices: train lead clinician + 
password access to GRAIDS software 
 22 comparison practices: educational meeting and 
mailed paper guidelines 
 



Software use and referrals 
 Software used 220 times 
during trial in 23 
practices (mean follow-
up 17 months) 
 Mean 7.7 uses per year 
per 10,000 registered 
patients 
 
 Referrals: 
 Intervention: 168 
 Control: 84 
 Intervention: 6.4 referrals 
per practice per year per 
10,000 registered patients 
 Control: 3.2 
 Mean difference 3.1 (95% CI 
1.4-4.9. p=0.001) 
 
Referrals II 
Intervention Control Odds Ratio (95% 
C.I.) 
Proportion 
meeting 
referral 
guidelines 
Breast 93% 
(99/107) 
75% 
(44/59) 
4.2 (1.5 to 12.2) 
Bowel 99% (75/76) 92% 
(23/25) 
6.5 (0.5 to 83.7) 
Combined 95% 
(174/183) 
80% 
(67/84) 
4.9 (1.6 to 14.8), 
p=0.007 
Proportion 
at 
increased 
risk 
determined 
by RGC 
Breast 77% (60/78) 70% 
(23/33) 
1.4 (0.6 to 3.5) 
Bowel 56% (30/54) 85% 
(17/20) 
0.2 (0.1 to 0.8) 
Combined 68% 
(90/132) 
75% 
(40/53) 
0.7 (0.3 to 1.5), 
p=0.35 
Patient outcomes 
Intervention arm Comparison 
arm 
Not referred Referred Mean diff Mean difference between 
referred populations 
 (95% CI) 
Knowledge  
Breast 
cancer 
NA 5.77 
n=65 
NA 5.66 
n=38 
0.11 (-1.05 to1.27) 
Colorectal 
cancer 
NA 5.70 
 n=44 
NA  4.86  
n=14 
0.64 (-1.01 to 2.29) 
Cancer 
worry 
4.95  
n=57 
5.74 
n=110 
0.79  
(-0.19 to 
1.76) 
7.18 
n=51 
1.44 (-2.64 to 
 -0.23) p=0.02 
Risk  
perception 
4.25  
n=51 
4.99 
n=104 
0.74 
 (0.38 to 
1.09)** 
P<0.0001 
5.04  
n=47 
0.09 (-0.34 to 0.51) 
Summary 
 Translating cancer risk models requires complex 
interventions with staged development and 
evaluation. 
 Importance of choice of risk model to translate and 
potential for unintended consequences 
 Practitioner-administered software needs to integrate 
with local practices and systems to increase likelihood 
of use. 
 Potential to improve assessment and management of 
people at increased risk of cancer in primary care 
  
Implementation 
research 
Integration into routine 
practice 
Why is GRAIDS not in 
routine practice?  
BMJ 2007;334: 445-459 Campbell, Murray, Darbyshire, Emery et al 
Context matters 
Limited bandwidth in NHSnet 
‘a sociological toolkit that 
we can use to understand 
the dynamics of 
implementing, embedding, 
and integrating some new 
technology or complex 
intervention in healthcare.’ 
Normalisation Process Theory 
 Coherence (sense-making) 
 Do GPs have a shared sense of purpose of the 
intervention and do they value the potential benefits? 
 
 Cognitive participation (engagement) 
 Do GPs see the point of the intervention and will they be 
prepared to invest time and energy to work on it? 
 
C May et al Sociology 2009; E Murray et al BMC Med 
2010 
Normalisation Process Theory 
 Collective action (work done to make intervention 
happen) 
 How compatible is the intervention with existing work 
practices and does it fit with the overall activities of the 
practice? 
 
 Reflexive monitoring (appraisal of benefits and costs) 
 Will GPs perceive benefits of the intervention once in use 
for a while? 
 Can the intervention be improved on basis of GP 
experience? 


• CETBIR 
Russell L. Gruen MBBS PhD FRACS 
 
Professor of Surgery & Public Health, The Alfred & Monash University 
Director, The National Trauma Research Institute  
NHMRC Practitioner Fellow 
Innovations in knowledge organisation: 
the evidence base in neurotrauma  

“It is surely a great 
criticism of our 
profession that we 
have not organised a 
critical summary, by 
specialty or 
subspecialty, of all 
relevant randomised 
controlled trials” 
 
-Archie Cochrane 
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New protocols
Existing protocols
New reviews
Updated reviews
Existing reviews, not incl updates
Reviews and protocols for reviews on 
The Cochrane Database of Systematic Reviews
Issue 1/2005 Alderson, 2005 
  
http://resources.iom.edu/widgets/systematic-review/infographic.html 
  
http://resources.iom.edu/widgets/systematic-review/infographic.html 
Four key challenges: 
 
• Deluge of biomedical research 
 
• Inefficient business processes 
 
• Duplication of effort 
 
• Poor engagement of end users 
  
  
Tricco, PLoS ONE 2008; 3:e3684 
Time to publication of Cochrane reviews 
Time from search to publication 
Sampson. J Clin Epi 2008; 61: 531-536 
Systematic review ‘survival’  
Shojania, Ann Int Med 2007; 147:224-233 
  
Systematic review standards 
  
“set a high bar  
that will be difficult to achieve 
 for many reviews,  
yet the evidence and experience 
are not reassuring that it is safe 
to cut corners if resources are 
limited” 
US Institute of Medicine. Finding what works in health care: standards for systematic reviews. 2011 
Trade-off between quality and currency 
Currency 
Q
ua
lit
y 
The vision 
 “The updating of trial overviews as new information 
becomes available may be a task for which electronic 
publishing has something to offer… 
 
 Besides registers of published and unpublished trials 
and trials in progress or planned, the [Oxford 
Database of Perinatal Trials] will include a library of 
trial overviews which will be updated when new data 
become available.” 
Chalmers. Lancet 1986; 328:287 
Living systematic reviews 
“comprehensive and authoritative compilations of systematic reviews…  
 accessible as living web-based resources.” 
 
Elliott JH, Gruen RL. Lancet 2007; 370:826 
Efficiency 
Participation 
Reuse 
Data 
deluge 
Quality 
Currency 
Utility 
The journey 
Moderate to Severe 
Traumatic Brain Injury 
in Victoria 
• Over 600 new cases per year 
• Major cause of mortality, long-term disability, 
individual, family and social loss 
• Estimated cost $2.2 billion/year * 
– Half is attributable to lost productivity 
– Two-thirds borne by individuals 
* Access Economics 2009 
Outcomes have not improved 
much in past 20 years 
• x 
Publications on TBI prognosis 1988-2011 
J Trauma Acute Care Surg 2012; 72: 585–93. 
 
 
17% compliance with BTF guidelines for craniotomy, 
intracranial pressure monitoring, and reversal of coagulopathy 
 
 
 
 
 
• Proportion with “good” outcomes would rise from 35% to 66% 
 
• Proportion with “poor” outcomes would fall from 34% to 19% 
J Trauma 2007, 6: 1271 – 1278   
Aims: 
 
• To improve outcomes for people with TBI 
 
• To create a network of neurotrauma clinicians and 
researchers with expertise in KT and evidence-
based practice 
 
• To contribute knowledge to the field of KT research 
 
 
NET Program 
Theme Program activity 
Theme 1: 
Evidence Resources 
Systematic reviews;  
Agreement on standards; 
Locally relevant guidelines 
Theme 2:  
Understanding Practice 
Data, Practice surveys & 
Interviews 
Theme 3:  
Planning & Instituting 
Change 
Theory-informed interventions; 
Intervention studies, including 
cluster RCTs 
Theme 4:  
Capacity Building 
Training;  
Clinician fellowships;  
Networks and collaboration  
The Global Evidence Mapping Initiative  
• Funded in 2007 by the Victoria Neurotrauma Initiative to 
develop ‘evidence maps’ to describe the available research in 
priority topics in Traumatic Brain Injury and Spinal Cord Injury 
 
• Pre-hospital, acute, rehabilitation and long-term care 
 
The Global Evidence Mapping Initiative 
Generate 
questions 
Prioritise 
questions 
Search for 
research 
Map 
research 
Identify 
gaps 
Generating & Prioritising Questions 
• Multiple phases 
– A. Expert consultation 
– B. Preliminary literature search  
– C. Mapping workshop 
– D. Online survey 
– E. Question development 
• Wide stakeholder engagement  
(policy-makers, managers, clinicians, consumers, carers, 
researchers)  
 
 
 
 
The Global Evidence Mapping Initiative 





continued… 
Intervention Trials Mortality Clinical ICP 
Pre-hospital Intubation 1 
Pre-hospital Hypertonic Saline 9 
Early volume resuscitation 1 
In Hospital Hypertonic Saline 8 
Mannitol 5 
Albumin 1 
Fresh frozen plasma 1 
Blood transfusion thresholds 1 
Tranexamic acid 3 
Erythropoietin 2 
Factor VIIa 1 
Rosuvastatin 1 
Hyperventilation 1 
CBF-directed management 1 
ICP-directed management 1 
PtO2-directed management 1 
Systemic hypothermia 19 
Cranial hypothermia 3 
Hyperoxia 5 
Steriods 16 
Isotonic Fluids Isotonic fluids Mannitol 
Mannitol  
Barbiturates 5 
Opioids 4 
Propofol 1 
Midazolam  1 
Progesterone 5 
Magnesium 2 
Nimodipine  3 
Cistracurium  1 
Anticonvulsants  7 
Bradykinin Antagonists 4 
Competitive N-methyl-D-aspartate 
antagonist (Selfotel) 
1 
Non-competitive N-methyl-D-aspartate 
antagonist (Traxoprodil) 
1 
Ciclosporine 2 
Tromethamine (THAM) 1 
Free radical scavenger (Pegorgotein or 
PEG SOD) 
1 
Oxidative stress/Lipid peroxidation 
inhibitor (Tirilazad) 
1 
NNZ 2566 1 
CDP-choline 1 
Cannabinoids (Dexanabinol) 2 
CSF drainage 1 
Nutrition – modes of delivery 5 
Nutrition – Rate/Timing of feeding 4 
Nutrition – Nutritional Agents 4 
- Low dose - High dose - High dose 

Adding value to a review 
Community Roadmap 
Cochrane Linked Data Project 
• Cochrane semantic web 
Living Systematic Reviews 
• Methods of collaboration & frequent updating 
 
• Technology to help the process 
 
• A community of participants engaged as 
curators of knowledge in their areas of 
expertise 
Search  
Excel, Word, Paper, Email… 
Living update process 
ReGroup 
 An online platform to improve the efficiency 
and experience of systematic review, 
particularly to allow multiple reviewers to 
collaborate on updating and maintaining living 
systematic reviews of topics 
 
 

Living Systematic Review Project 
“…comprehensive and authoritative systematic reviews  
designed, populated, and updated by international networks  
with content and methodological expertise… 
structured to incorporate important contextual characteristics, 
designed to help users interpret evidence and  
be accessible as living web-based resources.” 
 
Elliott JH, Gruen RL. Lancet 2007; 370:826 
Neurotrauma Knowledge Centres 

